<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02962791</url>
  </required_header>
  <id_info>
    <org_study_id>2016/091/HP</org_study_id>
    <nct_id>NCT02962791</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing in CRT canDidates</brief_title>
  <acronym>TRIPLEAD</acronym>
  <official_title>Prospective Randomized Trial Comparing TRIPLE Site ventriculAr Stimulation Versus Conventional Pacing in CRT canDidates: TRIPLEAD Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac resynchronization therapy (CRT) is a recommended treatment for selected patients with
      symptomatic heart failure (HF). Although most treated patients show a benefit from CRT, a
      lack of response is observed for about 25-30% of them whatever the response criteria used
      either based on the clinical status (NYHA class, Packer clinical composite score) or on
      ventricular remodeling parameters assessed by echography (Left ventricle end of systole
      volume). This rate has remained remarkably stable since the therapy started and has motivated
      many studies to better understand the underlying physiopathology and the CRT action
      mechanisms.

      Among the various research axes to improve CRT response and responders rate, increasing the
      number of pacing sites in an attempt to better homogenize the cardiac mechanical activity has
      been evaluated. A configuration with two RV leads and one LV lead was tested acutely in three
      studies. In all cases, it demonstrated a significant improvement of cardiac performance
      whether assessed by echographic parameters or LV dp/dt measurements. Additionally feasibility
      of this approach for long term CRT delivery was demonstrated during a previous study. First
      results with triple-site ventricular stimulation are encouraging and its clinical efficacy
      should now be tested on a larger population in order to conclude on its interest for CRT
      candidates.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference from baseline in Left Ventricular End-Systolic Volume</measure>
    <time_frame>12 months</time_frame>
    <description>Left Ventricular End-Systolic Volume will be evaluated using echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference from baseline in left ventricular remodelling</measure>
    <time_frame>12 months</time_frame>
    <description>Left ventricular remodelling will be evaluated using echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients alive</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">166</enrollment>
  <condition>Cardiac Resynchronization Therapy</condition>
  <arm_group>
    <arm_group_label>Stimulation of 3 ventricular sites</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cardiac resynchronization therapy implantation wil be done as usual, except the additional stimulation lead. Standard Echocardiography will be done at one year</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulation of 2 ventricular sites</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cardiac resynchronization therapy implantation wil be done as usual. Standard Echocardiography will be done at one year</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac resynchronization therapy implantation</intervention_name>
    <description>Cardiac resynchronization therapy implantation will be done for patient with symptomatic heart failure</description>
    <arm_group_label>Stimulation of 3 ventricular sites</arm_group_label>
    <arm_group_label>Stimulation of 2 ventricular sites</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimulation of 3 ventricular sites</intervention_name>
    <description>Cardiac resynchronization therapy with stimulation of 3 ventricular sites</description>
    <arm_group_label>Stimulation of 3 ventricular sites</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stimulation of 2 ventricular sites</intervention_name>
    <description>Cardiac resynchronization therapy with stimulation of 2 ventricular sites</description>
    <arm_group_label>Stimulation of 2 ventricular sites</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Standard Echocardiography will de bone for patient</description>
    <arm_group_label>Stimulation of 3 ventricular sites</arm_group_label>
    <arm_group_label>Stimulation of 2 ventricular sites</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient who signed the MEC approved informed consent

          -  Patient older than 18

          -  Patient with a CRT (CRT-P or D) indication as per ESC guidelines 2013

          -  Left Ventricular Ejection Fraction (LVEF) ≤ 35%

          -  NYHA class II/III/IV despite optimal medical treatment

          -  Left Bundle Branch Block (LBBB) and QRS ≥ 120 ms (class IA and IB indications) or in
             the absence of LBBB QRS &gt; 150 ms (class IIA indication)

          -  De novo implantation

          -  Sinus rhythm

        Exclusion Criteria:

          -  Permanent supra ventricular tachycardia

          -  Pacing indication for 3rd degree AV block

          -  Impossibility to perform FU at the investigative center

          -  Pregnancy

          -  Adults under legal protection

          -  Heart transplant candidates

          -  Concomitant pathology that may interfere with the study results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frédéric ANSELME, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frédéric ANSELME, Pr</last_name>
    <email>frederic.anselme@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT</last_name>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frédéric ANSELME, Pr</last_name>
    </contact>
    <investigator>
      <last_name>Frédéric ANSELME, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2016</study_first_posted>
  <last_update_submitted>November 9, 2016</last_update_submitted>
  <last_update_submitted_qc>November 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>symptomatic heart failure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

